Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN)

Historical Holders from Q2 2023 to Q3 2025

Symbol
VTGN on Nasdaq
CUSIP
92840H400
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
31.9M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
23.4M
Holdings value
$81.8M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
57
Number of buys
32
Number of sells
-16
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 13.6% $13.2M 4.17M JANUS HENDERSON GROUP PLC Aug 29, 2025
Nantahala Capital Management, LLC 9.99% 0% $11.1M $1.23M 3.19M +12.4% Nantahala Capital Management, LLC Sep 30, 2025
BIOTECHNOLOGY VALUE FUND L P 9.97% $6.35M 3.08M BVF PARTNERS L P/IL Dec 31, 2024
STEMPOINT CAPITAL LP 8.2% $4.8M 2.33M StemPoint Capital LP Dec 31, 2024
GREAT POINT PARTNERS LLC 6.28% -4.43% $7.18M 2.06M 0% Great Point Partners, LLC Sep 30, 2025
VANGUARD GROUP INC 5.5% $5.8M 1.69M The Vanguard Group Sep 30, 2025
ORBIMED ADVISORS LLC 5.34% $5.73M 1.64M ORBIMED CAPITAL LLC Sep 30, 2025

Institutional Holders of Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 23.4M $81.8M +$30.6M $3.55 57
2025 Q2 14.9M $29.8M -$918K $2.00 50
2025 Q1 15.3M $38.3M +$857K $2.50 47
2024 Q4 14.9M $44M -$1.1M $2.95 54
2024 Q3 14.6M $44.1M +$4.64M $3.01 47
2024 Q2 13M $45.4M -$5.79M $3.48 42
2024 Q1 14.6M $76.7M -$1.51M $5.28 41
2023 Q4 14.9M $76.1M +$50.5M $5.14 44
2023 Q3 3M $15.7M +$10.1M $5.24 34
2023 Q2 966K $1.81M +$1.81M $1.87 28